Desvenlafaxine
A team of investigators from the Department of Neurology has published a new study on new daily persistent headache (NDPH), a primary headache disorder characterized by the abrupt onset of continuous and unremitting headache within 24 hours of onset. The study, which involved a retrospective chart review of 328 patients
Desvenlafaxine
A team of investigators from the Department of Neurology has published a new study on new daily persistent headache (NDPH), a primary headache disorder characterized by the abrupt onset of continuous and unremitting headache within 24 hours of onset. The study, which involved a retrospective chart review of 328 patients
Desvenlafaxine
A team of investigators from the Department of Neurology has published a new study on new daily persistent headache (NDPH), a primary headache disorder characterized by the abrupt onset of continuous and unremitting headache within 24 hours of onset. The study, which involved a retrospective chart review of 328 patients
